January 5, 2010 – St. Paul’s Hospital in Vancouver, Canada recently was the first to use the Embrella Embolic Deflector cerebral protection system. The device uses a porous membrane to deflect emboli away from the carotid arteries. It is inserted through the right radial or right brachial artery, away from the femoral artery, which is the typical access site for procedures. The device was used in a 91-year-old patient undergoing a balloon aortic valvuloplasty (BAV) procedure. During BAV procedures there is a risk that atheromatous plaque may be dislodged and travel to the brain during the passage of catheters around the aortic arch or during the subsequent balloon dilation of the stenotic and calcified aortic valve. The device was inserted through the right radial artery, and passed through the brachiocephalic artery and positioned along the greater curvature of the aorta. The device remained in position during the entire BAV procedure. “We were pleased to see how well the device tracked into the aorta and how easily it was positioned. It covered the orifice of the brachiocephalic, left common carotid and the left subclavian arteries,” said Dr. John Webb, director of cardiac catheterization and interventional cardiology, St. Paul’s Hospital. “There was no interaction with the device as we advanced several wires and catheters past the Embrella device enroute to the aortic valve.” The Embrella Embolic Deflector device is not available for clinical use in the United States. For more information: www.embrellacardiovascular.net
News | January 04, 2010
New Embolic Defector Used in First Clinical Experience
Technology | Heart Valve Technology| August 15, 2017
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
News | Heart Valve Technology| August 03, 2017
Aug. 3, 2017 — 4C Medical Technologies Inc.
News | Heart Valve Technology| August 01, 2017
News | Cardiovascular Ultrasound| July 21, 2017
Hitachi and West Virginia University Partner to Advance Left Ventricular Mechanical Function Evaluation
Hitachi Healthcare and the West Virginia University Heart and Vascular Institute announced the formation of a new...
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
Technology | Computed Tomography (CT)| July 12, 2017
Ziosoft Enables True Fidelity Functional Visualization and Analytics For CT Structural Heart Assessments
July 12, 2017 — At the 2017 annual meeting for the Society of Cardiovascular Computed Tomography (SCCT), Ziosoft show
Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
News | Annuloplasty Rings| July 05, 2017
July 5, 2017 — BioStable Science & Engineering Inc.
News | Heart Valve Technology| June 30, 2017
June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthet